Invenomic Capital Management LP Has $50.09 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Invenomic Capital Management LP boosted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 201.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,639,161 shares of the medical instruments supplier's stock after purchasing an additional 1,762,428 shares during the period. DENTSPLY SIRONA accounts for 2.4% of Invenomic Capital Management LP's investment portfolio, making the stock its 2nd biggest holding. Invenomic Capital Management LP owned 1.33% of DENTSPLY SIRONA worth $50,091,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the business. Treasurer of the State of North Carolina raised its stake in shares of DENTSPLY SIRONA by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock valued at $1,686,000 after acquiring an additional 560 shares in the last quarter. UMB Bank n.a. raised its holdings in DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after acquiring an additional 564 shares during the period. Blue Trust Inc. grew its holdings in DENTSPLY SIRONA by 10.9% in the 4th quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier's stock valued at $137,000 after buying an additional 707 shares during the last quarter. Quarry LP grew its position in DENTSPLY SIRONA by 25.7% in the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after purchasing an additional 780 shares during the last quarter. Finally, Federated Hermes Inc. grew its holdings in shares of DENTSPLY SIRONA by 0.5% during the 4th quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock worth $3,213,000 after purchasing an additional 915 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Trading Down 0.9%

Shares of NASDAQ:XRAY traded down $0.15 during trading on Wednesday, hitting $16.45. 2,568,346 shares of the company's stock were exchanged, compared to its average volume of 2,958,551. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The firm has a market cap of $3.28 billion, a P/E ratio of -7.95, a PEG ratio of 1.80 and a beta of 0.92. The firm has a 50-day moving average price of $14.38 and a two-hundred day moving average price of $17.48. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $28.50.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. The firm had revenue of $879.00 million during the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business's quarterly revenue was down 7.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.42 EPS. Equities analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.89%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -14.10%.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, with a total value of $249,994.42. Following the purchase, the director now owns 81,971 shares of the company's stock, valued at $1,353,341.21. This represents a 22.66% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.50% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Wells Fargo & Company dropped their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Barrington Research boosted their price target on DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a research note on Monday. Jefferies Financial Group lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating and dropped their price objective for the stock from $30.00 to $20.00 in a research note on Thursday, January 23rd. StockNews.com raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Eleven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $20.36.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.